(Q36262284)

13 August 2017

title

Isolation and characterization of anti ROR1 single chain fragment variable antibodies using phage display technique (English)

1 reference

13 August 2017

0 references

Farhad Jadidi-Niaragh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28128766%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Mehdi Yousefi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28128766%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Leili Aghebati-Maleki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28128766%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Vahid Younesi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28128766%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Behzad Baradaran

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28128766%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Jafar Majidi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28128766%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

20 January 2017

1 reference

13 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28128766%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28128766%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28128766%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

57-63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28128766%20AND%20SRC:MED&resulttype=core&format=json

ROR1 contributes to melanoma cell growth and migration by regulating N-cadherin expression via the PI3K/Akt pathway.

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.3233%2FHAB-170310

Retracted: Inhibition of the Receptor Tyrosine Kinase ROR1 by Anti-ROR1 Monoclonal Antibodies and siRNA Induced Apoptosis of Melanoma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-170310

The receptor tyrosine kinase ROR1--an oncofetal antigen for targeted cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-170310

ROR1, an embryonic protein with an emerging role in cancer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-170310

Receptor tyrosine kinase-like orphan receptor 1: a novel target for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-170310

Restricted cell surface expression of receptor tyrosine kinase ROR1 in pediatric B-lineage acute lymphoblastic leukemia suggests targetability with therapeutic monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-170310

The onco-embryonic antigen ROR1 is expressed by a variety of human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-170310

Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-170310

Therapeutic potential and challenges of targeting receptor tyrosine kinase ROR1 with monoclonal antibodies in B-cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-170310

Targeting malignant B cells with an immunotoxin against ROR1

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-170310

Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-170310

Antiproliferative and apoptotic effects of a specific anti-insulin-like growth factor I receptor single chain antibody on breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-170310

Improving the efficacy of antibody-based cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-170310

Phage display as a promising approach for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-170310

Antibody phage display: technique and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-170310

Phage display--a powerful technique for immunotherapy: 1. Introduction and potential of therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-170310

21 January 2018

Identifiers

DOI

10.3233/HAB-170310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28128766%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference